These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9032508)

  • 21. The effect of positive end-expiratory pressure on respiratory resistive properties in anaesthetized paralysed humans.
    Cohendy R; Ripart J; Eledjam JJ
    Eur Respir J; 1994 Feb; 7(2):286-91. PubMed ID: 7909298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, followed by a 12-month trial with formoterol.
    Steffensen I; Faurschou P; Riska H; Rostrup J; Wegener T
    Allergy; 1995 Aug; 50(8):657-63. PubMed ID: 7503401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Forced expiratory flow and oscillometric impedance measurement in evaluating airway obstruction.
    Wouters EF; Mostert R; Polko AH; Visser BF
    Respir Med; 1990 May; 84(3):205-9. PubMed ID: 2218005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of salbutamol and Ro-20-1724 on airway and parenchymal mechanics in rats.
    Peták F; Wale JL; Sly PD
    J Appl Physiol (1985); 1999 Oct; 87(4):1373-80. PubMed ID: 10517766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No paradoxical bronchodilator response with forced oscillation technique in children with cystic fibrosis.
    Hellinckx J; De Boeck K; Demedts M
    Chest; 1998 Jan; 113(1):55-9. PubMed ID: 9440568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of changes in respiratory mechanics due to increasing degrees of airway obstruction in asthma by the forced oscillation technique.
    Cavalcanti JV; Lopes AJ; Jansen JM; Melo PL
    Respir Med; 2006 Dec; 100(12):2207-19. PubMed ID: 16713226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term efficacy of formoterol compared to salbutamol.
    Hekking PR; Maesen F; Greefhorst A; Prins J; Tan Y; Zweers P
    Lung; 1990; 168 Suppl():76-82. PubMed ID: 1974686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impedance measurement during air and helium-oxygen breathing before and after salbutamol in COPD patients.
    Wouters EF; Lándsér FJ; Polko AH; Visser BF
    Clin Exp Pharmacol Physiol; 1992 Feb; 19(2):95-101. PubMed ID: 1555329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bronchodilation in COPD: beyond FEV1-the effect of albuterol on resistive and reactive properties of the respiratory system.
    Costa GM; Faria AC; Di Mango AM; Lopes AJ; Jansen JM; Melo PL
    J Bras Pneumol; 2009 Apr; 35(4):325-33. PubMed ID: 19466270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bronchodilator response of advanced lung function parameters depending on COPD severity.
    Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility.
    Zhao H; Li R; Lv Y; Dong H; Yao L; Wu Y; Xiao G; Cai S
    Clin Respir J; 2017 May; 11(3):328-336. PubMed ID: 26077165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of lung and chest wall mechanics in patients with acute lung injury: effects of positive end-expiratory pressure.
    Pelosi P; Cereda M; Foti G; Giacomini M; Pesenti A
    Am J Respir Crit Care Med; 1995 Aug; 152(2):531-7. PubMed ID: 7633703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory mechanics in anaesthetised patients after neostigmine-atropine. A comparison between patients with and without chronic obstructive pulmonary disease.
    Bourgain JL; Debaene B; Meistelman C; Donati F
    Acta Anaesthesiol Scand; 1993 May; 37(4):365-9. PubMed ID: 8100667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Respiratory impedance and bronchodilator response in healthy Italian preschool children.
    Calogero C; Parri N; Baccini A; Cuomo B; Palumbo M; Novembre E; Morello P; Azzari C; de Martino M; Sly PD; Lombardi E
    Pediatr Pulmonol; 2010 Nov; 45(11):1086-94. PubMed ID: 20672294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oscillometry and pulmonary MRI measurements of ventilation heterogeneity in obstructive lung disease: relationship to quality of life and disease control.
    Young HM; Guo F; Eddy RL; Maksym G; Parraga G
    J Appl Physiol (1985); 2018 Jul; 125(1):73-85. PubMed ID: 29543132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salbutamol inhalation has no effect on myocardial ischaemia, arrhythmias and heart-rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease.
    Rossinen J; Partanen J; Stenius-Aarniala B; Nieminen MS
    J Intern Med; 1998 May; 243(5):361-6. PubMed ID: 9651558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of volatile anesthetics on respiratory system resistance in patients with chronic obstructive pulmonary disease.
    Volta CA; Alvisi V; Petrini S; Zardi S; Marangoni E; Ragazzi R; Capuzzo M; Alvisi R
    Anesth Analg; 2005 Feb; 100(2):348-353. PubMed ID: 15673854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Respiratory impedance and multibreath N2 washout in healthy, asthmatic, and cystic fibrosis subjects.
    Lutchen KR; Habib RH; Dorkin HL; Wall MA
    J Appl Physiol (1985); 1990 May; 68(5):2139-49. PubMed ID: 2361915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory impedance and bronchodilator responsiveness in healthy children aged 2-13 years.
    Calogero C; Simpson SJ; Lombardi E; Parri N; Cuomo B; Palumbo M; de Martino M; Shackleton C; Verheggen M; Gavidia T; Franklin PJ; Kusel MM; Park J; Sly PD; Hall GL
    Pediatr Pulmonol; 2013 Jul; 48(7):707-15. PubMed ID: 23169525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.